Women and children bear substantial morbidity and mortality as a result of armed conflicts. This Series paper focuses on the direct (due to violence) and indirect health effects of armed conflict on women and children (including adolescents) worldwide. We estimate that nearly 36 million children and 16 million women were displaced in 2017, on the basis of international databases of refugees and internally displaced populations.
Background: The incidence of metastatic spine disease (MSD) is increasing among cancer patients. Given the poor outcomes and high rates of morbidity associated with MSD, it is important to determine demographic factors that could impact interventions and outcomes for this patient population. The objectives of this study were to compare in-hospital mortality and complication rates, clinical presentation, and interventions between female and male patients diagnosed with MSD.
Our nationwide network of BME women faculty collectively argue that racial funding disparity by the National Institutes of Health (NIH) remains the most insidious barrier to success of Black faculty in our profession. We thus refocus attention on this critical barrier and suggest solutions on how it can be dismantled.
COVID-19, Obesity, and Structural Racism.
This article examines how improved water security affects the success of other SDGs, when all the goals are examined simultaneously.
A framework for understanding water's many functions for supporting, regulating, and stabilizing hydro-climatic, hydro-ecological, and hydro-social systems.
This Lancet Global Health Commission advances addresses SDG 3 directly, and SDGs 1, 2, 4, 5, 8 and 10 indirectly, by comprehensively demonstrating how improving eye health by treating and preventing vision impairment and vision loss can not only advance SDG 3—improving health and wellbeing for all—but also contribute to poverty reduction, zero hunger, quality education, gender equality, and decent work and economic growth. The findings of this report frame eye health as a development issue and highlight that, with a growing ageing population globally, urgent and concerted action is needed to meet unmet eye health needs globally, including incorporating equitable eye care into countries’ universal health coverage plans.
Background: In 2016, of the estimated 257 million people living with chronic hepatitis B virus (HBV) infection worldwide, only a small proportion was diagnosed and treated. The insufficiency of information on the proportion of people infected with HBV who are eligible for treatment limits the interpretation of global treatment coverage. We aimed to estimate the proportion of people with chronic HBV infection who were eligible for antiviral treatment worldwide, based on the WHO 2015 guidelines.
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals
Hepatitis B virus (HBV) poses a major global health burden with 260 million people being chronically infected and 890,000 dying annually from complications in the course of the infection. HBV is a small enveloped virus with a reverse-transcribed DNA genome that infects hepatocytes and can cause acute and chronic infections of the liver. HBV is endemic in humans and apes representing the prototype member of the viral family Hepadnaviridae and can be divided into 10 genotypes.
A Research Paper on obesity, in the context of SDGs 3, 9, and 11, focusing specifically on the role of multi-level and multi-component interventions addressing healthy nutrition, physical activity, and education to mitigate the rising epidemic.
